FDA had cancelled Ranbaxy's approvals to launch generic Nexium, Valcyte Ranbaxy Laboratories Ltd has sued the US Food and Drug Administration (FDA) for revoking approvals granted to the firm to......
A US court has denied a request by drugmaker Ranbaxy Laboratories Ltd to stop competitors from launching copies of AstraZeneca Plc's heartburn pill Nexium and Roche's antiviral Valcyte, a court......
The Indian arm of Swiss drug maker F Hoffman-La Roche Scientific has filed two separate petitions against Cipla in the Bombay high court alleging patent and trademark infringements over its......
The FDA has been tightening its monitoring of Indian pharma majors over compliance issues. Surprise plant inspections and import alerts have been frequent outcomes The US Food & Drug Administration......
The Valcyte case is vital as it bars incremental innovation and recognises the right of patient groups to oppose patents, says Latha Jishnu. Patent challenges may be routine and as frequent as......